
Soligenix SNGX
€ 0.98
0.51%
Geschäftsbericht 2025
hinzugefügt 31.03.2026
Soligenix P/CF 2011-2026 | SNGX
P/CF Jährlich Soligenix
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.596 | -0.233 | -0.559 | -0.438 | -0.15 | -3.72 | -6.32 | -1.64 | -2.09 | -1.77 | -4.24 | -9.43 | -7.95 | -6.96 | -4.17 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -0.15 | -9.43 | -3.35 |
P/CF anderer Aktien in der Pharmaeinzelhändler
| Name | P/CF | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Acorda Therapeutics
ACOR
|
-1.2 | - | -24.86 % | $ 820 K | ||
|
Adverum Biotechnologies
ADVM
|
-0.826 | - | - | $ 86.2 M | ||
|
MorphoSys AG
MOR
|
-0.654 | - | 2.43 % | $ 254 M | ||
|
Alterity Therapeutics Limited
ATHE
|
-94.9 | $ 3.85 | 3.22 % | $ 9.26 B | ||
|
Akouos
AKUS
|
-2.7 | - | 0.23 % | $ 488 M | ||
|
Alnylam Pharmaceuticals
ALNY
|
77.9 | $ 326.45 | -2.08 % | $ 42.8 B | ||
|
Applied Molecular Transport
AMTI
|
-0.236 | - | - | $ 10.1 M | ||
|
I-Mab
IMAB
|
-0.266 | - | - | $ 866 M | ||
|
AlloVir
ALVR
|
-0.632 | - | 4.14 % | $ 49.1 M | ||
|
Burford Capital Limited
BUR
|
11.6 | $ 4.71 | -0.42 % | $ 766 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
11.6 | - | - | $ 40.3 B | ||
|
Cabaletta Bio
CABA
|
-2.16 | $ 3.49 | 2.65 % | $ 351 M | ||
|
Genfit SA
GNFT
|
1.68 K | - | 2.54 % | $ 160 B | ||
|
Biophytis SA
BPTS
|
-23.1 | - | -13.47 % | $ 169 M | ||
|
Aligos Therapeutics
ALGS
|
-0.799 | $ 8.14 | 9.7 % | $ 80.5 M | ||
|
Allakos
ALLK
|
-0.976 | - | - | $ 28.6 M | ||
|
Ayala Pharmaceuticals
AYLA
|
-0.224 | - | - | $ 7.46 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.88 | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
-13.2 | - | -18.52 % | $ 27.3 M | ||
|
Applied Therapeutics
APLT
|
-9.8 | - | - | $ 8.42 M | ||
|
Aptinyx
APTX
|
-0.159 | - | -39.0 % | $ 4.57 M | ||
|
Aravive
ARAV
|
-0.928 | - | -13.39 % | $ 1.45 M | ||
|
Brainstorm Cell Therapeutics
BCLI
|
-0.696 | - | -2.5 % | $ 5.88 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
8 | $ 21.85 | 0.78 % | $ 1.02 B | ||
|
CymaBay Therapeutics
CBAY
|
-47.3 | - | - | $ 3.45 B | ||
|
BioNTech SE
BNTX
|
70.7 | $ 101.25 | 1.78 % | $ 27.2 B | ||
|
Институт стволовых клеток человека
ISKJ
|
-89 | - | - | - | ||
|
Advaxis
ADXS
|
-0.0633 | - | -9.65 % | $ 45.9 M | ||
|
Aeterna Zentaris
AEZS
|
-4.82 | - | 5.93 % | $ 314 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-0.537 | $ 3.15 | -0.63 % | $ 5.19 M | ||
|
AgeX Therapeutics
AGE
|
-0.0018 | - | -10.17 % | $ 12.2 K | ||
|
ContraFect Corporation
CFRX
|
-0.0235 | - | -5.16 % | $ 5.39 M | ||
|
Galectin Therapeutics
GALT
|
-7.47 | $ 2.3 | -10.16 % | $ 147 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-4.6 | - | - | $ 1.01 B | ||
|
Akebia Therapeutics
AKBA
|
4.92 | $ 1.4 | -10.0 % | $ 360 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-0.64 | - | - | $ 26.5 M | ||
|
Aquestive Therapeutics
AQST
|
-8.91 | $ 4.22 | -0.5 % | $ 451 M | ||
|
Arcutis Biotherapeutics
ARQT
|
-612 | $ 23.98 | -2.44 % | $ 3.05 B | ||
|
Grifols, S.A.
GRFS
|
14.1 | $ 8.58 | -1.29 % | $ 6.83 B | ||
|
AIkido Pharma
AIKI
|
-1.17 | - | 1.93 % | $ 17.4 M | ||
|
BioDelivery Sciences International
BDSI
|
7.5 | - | -4.8 % | $ 255 M | ||
|
Autolus Therapeutics plc
AUTL
|
-1.14 | $ 1.53 | 2.35 % | $ 407 M | ||
|
Aptose Biosciences
APTO
|
-0.0645 | - | -45.71 % | $ 1.2 M | ||
|
BeiGene, Ltd.
BGNE
|
-1.8 K | - | 0.49 % | $ 251 B | ||
|
Checkpoint Therapeutics
CKPT
|
-5.15 | - | - | $ 169 M | ||
|
Caladrius Biosciences
CLBS
|
-0.185 | - | -16.75 % | $ 25.8 M | ||
|
AVROBIO
AVRO
|
-0.891 | - | 1083.1 % | $ 745 M | ||
|
Clearside Biomedical
CLSD
|
-5.59 | - | - | $ 25.3 M | ||
|
Celldex Therapeutics
CLDX
|
-9.67 | $ 33.75 | -0.35 % | $ 2.24 B | ||
|
bluebird bio
BLUE
|
-0.285 | - | - | $ 546 M |